Peter T Lin, MD
Neurology · Los Gatos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 25
- 6 carriers
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
25 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lin’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A79891 · Delinquent
Licence status: Delinquent · since 2002 · expires 2026-03-31 · University of Michigan Medical School.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$272,698
Medicare paid this office $272,698 for 266 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 40 | $105,565 | None |
| Return visit (30+ min) | 241 | $86,661 | $110 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 22 | $12,056 | $180 |
| Face injection for nerve paralysis | 15 | $7,755 | $176 |
| Muscle electrical test | 27 | $6,493 | $79 |
See all 13 services
| Botox | 40 | $105,565 | None |
| Return visit (30+ min) | 241 | $86,661 | $110 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 22 | $12,056 | $180 |
| Face injection for nerve paralysis | 15 | $7,755 | $176 |
| Muscle electrical test | 27 | $6,493 | $79 |
| New patient visit (45+ min) | 45 | $6,375 | $142 |
| Exam of neurobehavioral status, first hour | 70 | $5,888 | $83 |
| Advance care planning, first 30 minutes | 66 | $4,786 | $71 |
| Annual depression screening, 5 to 15 minutes | 82 | $1,965 | $24 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 19 | $1,628 | $43 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 14 | $1,294 | $38 |
| Telephone medical discussion with physician, 11-20 minutes | 12 | $1,229 | $82 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $634 | $53 |
Who their Medicare patients are
266 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 12% · Women 48% · Also on Medicaid 18% · Health risk score 1.27. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 57% · Depression 24% · Diabetes 21% · Coronary heart disease 16% · Cancer 14% · Dementia 14% · Chronic kidney disease 13% · Atrial fibrillation 13% · Heart failure 7% · Stroke 7% · COPD 6%.
The office billed $728,225, Medicare allowed $355,512 and paid $272,698; for 28,669 services of 27 kinds; $126,171 of it was for drugs given in the office and $146,527 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 266 | 28,669 | 75 | 1.27 | $728,225 | $272,698 |
| 2023 | 324 | 23,892 | 75 | 1.30 | $754,503 | $241,915 |
| 2022 | 327 | 22,775 | 75 | 1.29 | $694,577 | $247,476 |
| 2021 | 323 | 17,861 | 75 | 1.39 | $506,393 | $196,271 |
| 2020 | 285 | 11,993 | 74 | 1.50 | $390,764 | $135,641 |
| 2019 | 241 | 15,197 | 74 | 1.29 | $370,536 | $160,120 |
| 2018 | 177 | 14,070 | 74 | 1.37 | $304,600 | $141,567 |
| 2017 | 123 | 11,571 | 74 | 1.34 | $201,530 | $102,793 |
| 2016 | 81 | 8,449 | 72 | 1.43 | $147,925 | $75,403 |
| 2015 | 50 | 1,414 | 70 | 1.64 | $33,800 | $19,278 |
| 2014 | 259 | 467 | 65 | 1.56 | $247,422 | $30,342 |
| 2013 | 299 | 577 | 66 | 1.62 | $234,703 | $36,004 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Botox | 34 | $85,491 | None |
| Return visit (30+ min) | 234 | $73,189 | $104 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 15 | $8,901 | $182 |
| Face injection for nerve paralysis | 14 | $7,756 | $180 |
| New patient visit (45+ min) | 49 | $6,867 | $140 |
| Return visit (30+ min) | 46 | $5,588 | $74 |
| Muscle electrical test | 21 | $5,048 | $79 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 20 | $2,874 | $43 |
| Exam of neurobehavioral status, first hour | 34 | $2,866 | $84 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 17 | $2,693 | $39 |
| Annual depression screening, 5 to 15 minutes | 99 | $2,308 | $23 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,850 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 15 | $976 | $51 |
2022: 16 services
| Botox | 31 | $82,267 | None |
| Return visit (30+ min) | 229 | $77,494 | $108 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 13 | $8,627 | $188 |
| New patient visit (45+ min) | 55 | $8,027 | $146 |
| Face injection for nerve paralysis | 14 | $7,594 | $185 |
| Return visit (30+ min) | 42 | $5,321 | $77 |
| Muscle electrical test | 18 | $4,882 | $86 |
| Exam of neurobehavioral status, first hour | 57 | $4,464 | $78 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 20 | $4,368 | $41 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 24 | $3,195 | $46 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $2,011 | $87 |
| Annual depression screening, 5 to 15 minutes | 87 | $2,006 | $23 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,787 | $51 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $569 | $52 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $468 | $19 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 15 | $210 | $12 |
2021: 15 services
| Botox | 24 | $63,684 | None |
| Return visit (30+ min) | 198 | $59,407 | $104 |
| New patient visit (45+ min) | 46 | $6,860 | $149 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 11 | $5,986 | $166 |
| Face injection for nerve paralysis | 11 | $5,803 | $187 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 25 | $5,208 | $39 |
| Muscle electrical test | 17 | $4,438 | $89 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 26 | $3,766 | $44 |
| Return visit (30+ min) | 31 | $3,347 | $90 |
| Telephone medical discussion with physician, 5-10 minutes | 44 | $1,885 | $24 |
| Short return visit (20+ min) | 28 | $1,801 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,573 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,420 | $75 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $635 | $49 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 19 | $369 | $13 |
2020: 15 services
| Botox | 19 | $40,306 | None |
| Return visit (30+ min) | 168 | $36,257 | $75 |
| New patient visit (45+ min) | 63 | $8,193 | $130 |
| Face injection for nerve paralysis | 12 | $6,121 | $185 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 18 | $5,191 | $42 |
| Telephone medical discussion with physician, 11-20 minutes | 43 | $2,925 | $42 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 18 | $2,915 | $46 |
| Muscle electrical test | 13 | $2,459 | $82 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,526 | $64 |
| Short return visit (20+ min) | 23 | $1,299 | $48 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 33 | $1,126 | $13 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $701 | $39 |
| Annual depression screening, 5 to 15 minutes | 28 | $632 | $23 |
| Telephone medical discussion with physician, 5-10 minutes | 27 | $602 | $17 |
| Short return visit (20+ min) | 18 | $342 | $17 |
2019: 11 services
| Botox | 25 | $56,621 | None |
| Return visit (30+ min) | 154 | $48,338 | $94 |
| New patient visit (45+ min) | 68 | $9,573 | $141 |
| Face injection for nerve paralysis | 19 | $8,755 | $175 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 16 | $6,716 | $160 |
| Muscle electrical test | 20 | $3,921 | $78 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | 13 | $3,527 | $37 |
| Ultrasonic guidance for needle placement | 12 | $2,078 | $55 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | 13 | $1,724 | $44 |
| Short return visit (20+ min) | 28 | $1,602 | $42 |
| Annual depression screening, 5 to 15 minutes | 32 | $714 | $22 |
2018: 9 services
| Botox | 24 | $49,701 | None |
| Return visit (30+ min) | 120 | $34,482 | $94 |
| New patient visit (45+ min) | 90 | $12,517 | $139 |
| Face injection for nerve paralysis | 12 | $7,585 | $181 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 16 | $6,356 | $141 |
| Muscle electrical test | 22 | $3,916 | $73 |
| Ultrasonic guidance for needle placement | 14 | $2,865 | $58 |
| Exam of neurobehavioral status, first hour | 18 | $1,522 | $85 |
| Annual depression screening, 5 to 15 minutes | 21 | $468 | $22 |
2017: 7 services
| Botox | 21 | $40,779 | None |
| Return visit (30+ min) | 72 | $18,140 | $95 |
| New patient visit (45+ min) | 57 | $8,377 | $147 |
| Face injection for nerve paralysis | 12 | $6,083 | $179 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 13 | $5,081 | $134 |
| Muscle electrical test | 21 | $3,289 | $71 |
| Ultrasonic guidance for needle placement | 16 | $2,384 | $58 |
2016: 6 services
| Botox | 15 | $29,661 | None |
| Return visit (30+ min) | 51 | $12,280 | $92 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 12 | $4,805 | $146 |
| New patient visit (45+ min) | 33 | $4,702 | $142 |
| Muscle electrical test | 14 | $2,477 | $75 |
| Ultrasonic guidance for needle placement | 14 | $2,413 | $59 |
2015: 1 service
| Return visit (30+ min) | 23 | $4,403 | $100 |
2014: 8 services
| Short return visit (20+ min) | 145 | $6,680 | $33 |
| Face injection for nerve paralysis | 18 | $4,934 | $127 |
| Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | 11 | $2,717 | $113 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 25 | $2,232 | $86 |
| Return visit (30+ min) | 34 | $2,168 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,870 | $60 |
| New patient visit (45+ min) | 18 | $1,588 | $88 |
| Muscle electrical test | 13 | $345 | $15 |
2013: 8 services
| Short return visit (20+ min) | 200 | $12,068 | $36 |
| Face injection for nerve paralysis | 31 | $7,402 | $114 |
| Injection of chemical for destruction of neck muscles | 17 | $5,476 | $166 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,774 | $118 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,674 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,109 | $58 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $496 | $33 |
| Muscle electrical test | 13 | $294 | $17 |
Medicaid work
$1,522 in 2024
Medicaid paid $1,522 for 112 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 112 | $1,522 |
| 2024 | 112 | 1 | 20 | $1,522 |
| 2023 | 496 | 2 | 31 | $5,725 |
| 2022 | 340 | 2 | 21 | $4,575 |
| 2021 | 138 | 2 | 19 | $2,375 |
| 2020 | 34 | 2 | 19 | $320 |
| 2019 | 31 | 1 | 18 | $65 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 307 | $3,488 |
| Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine) | 189 | $2,237 |
2022
| Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine) | 139 | $2,466 |
| Return visit (30+ min) | 201 | $2,108 |
2021
| Chemodenervation of muscle(s); muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (eg, for chronic migraine) | 105 | $2,011 |
| Return visit (30+ min) | 33 | $364 |
2020
| Short return visit (20+ min) | 21 | $301 |
| Short return visit | 13 | $20 |
2019
| Short return visit (20+ min) | 31 | $65 |
Drugs they prescribed that Part D paid
$1,608,133
Pharmacies billed $1,608,133 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (32 of 4,107) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%. Long-acting opioids: 34% of their opioid prescriptions.
3,303 generic and fewer than 11 brand-name prescriptions · $1,608,133 in drug cost · 230 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rytary | Parkinson's | 242 | $396,156 | $1,637 |
| Nuplazid | Parkinson's psychosis | 66 | $285,142 | $4,320 |
| Gocovri | None | 63 | $181,977 | $2,889 |
| Neupro | None | 158 | $178,985 | $1,133 |
| Nourianz | None | 45 | $100,883 | $2,242 |
See all 58 drugs
| Rytary | Parkinson's | 242 | $396,156 | $1,637 |
| Nuplazid | Parkinson's psychosis | 66 | $285,142 | $4,320 |
| Gocovri | None | 63 | $181,977 | $2,889 |
| Neupro | None | 158 | $178,985 | $1,133 |
| Nourianz | None | 45 | $100,883 | $2,242 |
| Botox | None | 39 | $40,693 | $1,043 |
| Ongentys | None | 32 | $32,108 | $1,003 |
| Carbidopa-Levodopa | None | 743 | $31,768 | $43 |
| Nurtec Odt | None | 23 | $28,569 | $1,242 |
| Entacapone | None | 96 | $19,506 | $203 |
| Rasagiline Mesylate | None | 63 | $13,672 | $217 |
| Amantadine | None | 231 | $12,248 | $53 |
| Emgality | Migraine | 18 | $11,666 | $648 |
| Carbidopa-Levodopa Er | None | 204 | $8,550 | $42 |
| Carbidopa-Levodopa-Entacapone | None | 20 | $8,534 | $427 |
| Myrbetriq | None | 11 | $6,522 | $593 |
| Ropinirole Er | None | 46 | $5,593 | $122 |
| Rivastigmine | None | 32 | $4,960 | $155 |
| Quetiapine | None | 162 | $4,216 | $26 |
| Gabapentin | None | 179 | $3,561 | $20 |
| Selegiline | None | 55 | $3,190 | $58 |
| Ropinirole | None | 55 | $2,529 | $46 |
| Rivastigmine | None | 70 | $2,307 | $33 |
| Pramipexole Dihydrochloride | None | 100 | $1,824 | $18 |
| Escitalopram | None | 110 | $1,646 | $15 |
| Memantine | None | 53 | $1,385 | $26 |
| Topiramate | None | 47 | $1,230 | $26 |
| Pregabalin | None | 31 | $1,230 | $40 |
| Donepezil | None | 79 | $1,084 | $14 |
| Fludrocortisone Acetate | None | 36 | $998 | $28 |
| Midodrine | None | 26 | $973 | $37 |
| Clonazepam | None | 91 | $934 | $10 |
| Nortriptyline | None | 51 | $909 | $18 |
| Methylphenidate | None | 36 | $662 | $18 |
| Hydrocodone-Acetaminophen | None | 13 | $658 | $51 |
| Duloxetine | None | 23 | $648 | $28 |
| Propranolol | None | 61 | $623 | $10 |
| Dalfampridine Er | None | 11 | $589 | $54 |
| Mirtazapine | None | 31 | $538 | $17 |
| Modafinil | None | 12 | $507 | $42 |
| Primidone | None | 25 | $472 | $19 |
| Trazodone | None | 51 | $465 | $9 |
| Propranolol Hcl Er | None | 17 | $350 | $21 |
| Lorazepam | None | 29 | $335 | $12 |
| Venlafaxine Hcl Er | None | 14 | $326 | $23 |
| Paroxetine | None | 15 | $276 | $18 |
| Ipratropium | None | 16 | $263 | $16 |
| Trihexyphenidyl | None | 26 | $254 | $10 |
| Amitriptyline | None | 13 | $235 | $18 |
| Methadone | None | 11 | $217 | $20 |
| Alprazolam | None | 33 | $183 | $6 |
| Zonisamide | None | 15 | $180 | $12 |
| Diazepam | None | 23 | $119 | $5 |
| Rizatriptan | None | 15 | $108 | $7 |
| Temazepam | None | 25 | $98 | $4 |
| Cyclobenzaprine | None | 11 | $62 | $6 |
| Zolpidem | None | 23 | $41 | $2 |
| Citalopram Hbr | None | 11 | $20 | $2 |
Year by year
| 2024 | 4,107 | 391 | 1% (32) | None | $1,608,133 |
| 2023 | 4,652 | 383 | 1% (26) | None | $1,776,071 |
| 2022 | 4,628 | 388 | None | 17% | $1,658,991 |
| 2021 | 4,185 | 359 | None | 20% | $1,621,066 |
| 2020 | 3,543 | 300 | 1% (26) | 17% | $1,174,169 |
| 2019 | 2,816 | 218 | 1% (25) | 22% | $1,000,316 |
| 2018 | 2,075 | 151 | 2% (35) | 19% | $581,853 |
| 2017 | 1,177 | 98 | 2% (18) | 23% | $362,214 |
| 2016 | 844 | 88 | 2% (13) | None | $173,907 |
| 2015 | 1,833 | 219 | 2% (41) | 12% | $314,263 |
| 2014 | 2,306 | 217 | 5% (112) | 10% | $227,857 |
| 2013 | 2,190 | 199 | 8% (171) | None | $188,045 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 65 drugs
| Rytary | Parkinson's | 178 | $329,400 | $1,851 |
| Nuplazid | Parkinson's psychosis | 51 | $292,296 | $5,731 |
| Neupro | None | 177 | $209,081 | $1,181 |
| Gocovri | None | 61 | $144,881 | $2,375 |
| Nourianz | None | 28 | $88,049 | $3,145 |
| Carbidopa-Levodopa | None | 972 | $56,647 | $58 |
| Botox | None | 36 | $43,850 | $1,218 |
| Nurtec Odt | None | 22 | $33,700 | $1,532 |
| Entacapone | None | 85 | $27,933 | $329 |
| Rasagiline Mesylate | None | 64 | $25,826 | $404 |
| Amantadine | None | 325 | $22,699 | $70 |
| Ongentys | None | 14 | $17,581 | $1,256 |
| Aimovig | Migraine | 20 | $15,209 | $760 |
| Tetrabenazine | None | 12 | $13,207 | $1,101 |
| Myrbetriq | None | 22 | $13,101 | $595 |
| Carbidopa-Levodopa-Entacapone | None | 35 | $12,525 | $358 |
| Carbidopa-Levodopa Er | None | 192 | $12,039 | $63 |
| Quetiapine | None | 194 | $11,203 | $58 |
| Linzess | None | 18 | $10,391 | $577 |
| Emgality | Migraine | 13 | $9,537 | $734 |
| Pramipexole Dihydrochloride | None | 107 | $9,248 | $86 |
| Rivastigmine | None | 133 | $8,057 | $61 |
| Rivastigmine | None | 34 | $7,931 | $233 |
| Selegiline | None | 75 | $7,867 | $105 |
| Pramipexole Er | None | 16 | $6,873 | $430 |
| Gabapentin | None | 201 | $6,089 | $30 |
| Midodrine | None | 53 | $5,397 | $102 |
| Ropinirole Er | None | 50 | $4,883 | $98 |
| Fludrocortisone Acetate | None | 59 | $3,317 | $56 |
| Topiramate | None | 68 | $3,217 | $47 |
| Ropinirole | None | 86 | $3,055 | $36 |
| Atomoxetine | None | 16 | $2,882 | $180 |
| Primidone | None | 41 | $2,775 | $68 |
| Escitalopram | None | 106 | $1,946 | $18 |
| Memantine | None | 72 | $1,523 | $21 |
| Solifenacin | None | 13 | $1,494 | $115 |
| Clonazepam | None | 109 | $1,442 | $13 |
| Methylphenidate | None | 36 | $1,404 | $39 |
| Trazodone | None | 55 | $1,275 | $23 |
| Propranolol Hcl Er | None | 12 | $1,171 | $98 |
| Pregabalin | None | 29 | $1,099 | $38 |
| Galantamine Hbr | None | 20 | $1,004 | $50 |
| Propranolol | None | 32 | $964 | $30 |
| Donepezil | None | 57 | $963 | $17 |
| Duloxetine | None | 21 | $848 | $40 |
| Nortriptyline | None | 50 | $828 | $17 |
| Pyridostigmine | None | 16 | $807 | $50 |
| Trihexyphenidyl | None | 31 | $761 | $25 |
| Oxazepam | None | 20 | $718 | $36 |
| Baclofen | None | 22 | $705 | $32 |
| Hydrocodone-Acetaminophen | None | 13 | $619 | $48 |
| Venlafaxine Hcl Er | None | 22 | $593 | $27 |
| Clozapine | None | 17 | $380 | $22 |
| Zolpidem | None | 22 | $324 | $15 |
| Lorazepam | None | 21 | $294 | $14 |
| Zonisamide | None | 14 | $271 | $19 |
| Mirtazapine | None | 18 | $266 | $15 |
| Sertraline | None | 13 | $226 | $17 |
| Rizatriptan | None | 13 | $203 | $16 |
| Paroxetine | None | 12 | $144 | $12 |
| Amitriptyline | None | 12 | $109 | $9 |
| Alprazolam | None | 28 | $108 | $4 |
| Temazepam | None | 24 | $99 | $4 |
| Diazepam | None | 31 | $66 | $2 |
| Sildenafil Citrate | None | 11 | $25 | $2 |
2022: 63 drugs
| Rytary | Parkinson's | 198 | $325,061 | $1,642 |
| Nuplazid | Parkinson's psychosis | 65 | $313,108 | $4,817 |
| Neupro | None | 134 | $153,952 | $1,149 |
| Nourianz | None | 51 | $121,241 | $2,377 |
| Gocovri | None | 41 | $73,054 | $1,782 |
| Botox | None | 38 | $47,039 | $1,238 |
| Carbidopa-Levodopa | None | 926 | $46,457 | $50 |
| Nurtec Odt | None | 33 | $39,519 | $1,198 |
| Amantadine | None | 351 | $30,951 | $88 |
| Rasagiline Mesylate | None | 46 | $22,155 | $482 |
| Pramipexole Er | None | 26 | $20,542 | $790 |
| Ongentys | None | 18 | $19,432 | $1,080 |
| Droxidopa | None | 22 | $18,371 | $835 |
| Entacapone | None | 57 | $14,630 | $257 |
| Carbidopa-Levodopa Er | None | 184 | $14,540 | $79 |
| Myrbetriq | None | 24 | $14,377 | $599 |
| Carbidopa-Levodopa-Entacapone | None | 33 | $10,621 | $322 |
| Rivastigmine | None | 30 | $9,813 | $327 |
| Exelon | None | 13 | $9,638 | $741 |
| Aimovig | Migraine | 11 | $8,676 | $789 |
| Midodrine | None | 51 | $7,665 | $150 |
| Rivastigmine | None | 142 | $7,182 | $51 |
| Emgality | Migraine | 11 | $7,068 | $643 |
| Quetiapine | None | 206 | $7,011 | $34 |
| Gabapentin | None | 226 | $5,814 | $26 |
| Pramipexole Dihydrochloride | None | 95 | $5,212 | $55 |
| Selegiline | None | 60 | $4,761 | $79 |
| Ropinirole Er | None | 37 | $3,157 | $85 |
| Fludrocortisone Acetate | None | 30 | $2,736 | $91 |
| Propranolol Hcl Er | None | 19 | $2,709 | $143 |
| Topiramate | None | 70 | $2,225 | $32 |
| Ropinirole | None | 70 | $2,174 | $31 |
| Memantine | None | 63 | $2,041 | $32 |
| Pregabalin | None | 50 | $1,869 | $37 |
| Escitalopram | None | 110 | $1,796 | $16 |
| Galantamine Hbr | None | 24 | $1,773 | $74 |
| Solifenacin | None | 12 | $1,542 | $128 |
| Clonazepam | None | 92 | $1,506 | $16 |
| Duloxetine | None | 26 | $1,370 | $53 |
| Methylphenidate | None | 37 | $1,330 | $36 |
| Ramelteon | None | 16 | $1,160 | $73 |
| Primidone | None | 32 | $1,016 | $32 |
| Trazodone | None | 82 | $987 | $12 |
| Clozapine | None | 36 | $914 | $25 |
| Fluvoxamine Maleate | None | 11 | $894 | $81 |
| Propranolol | None | 21 | $827 | $39 |
| Oxazepam | None | 26 | $773 | $30 |
| Zolpidem | None | 26 | $693 | $27 |
| Venlafaxine Hcl Er | None | 21 | $687 | $33 |
| Trihexyphenidyl | None | 48 | $613 | $13 |
| Donepezil | None | 37 | $546 | $15 |
| Lorazepam | None | 31 | $489 | $16 |
| Amitriptyline | None | 13 | $463 | $36 |
| Nortriptyline | None | 49 | $442 | $9 |
| Ondansetron | None | 11 | $421 | $38 |
| Rizatriptan | None | 21 | $408 | $19 |
| Mirtazapine | None | 24 | $279 | $12 |
| Sumatriptan | None | 18 | $259 | $14 |
| Benztropine Mesylate | None | 13 | $248 | $19 |
| Zonisamide | None | 13 | $157 | $12 |
| Temazepam | None | 26 | $120 | $5 |
| Diazepam | None | 37 | $81 | $2 |
| Alprazolam | None | 25 | $68 | $3 |
2021: 65 drugs
| Rytary | Parkinson's | 264 | $317,010 | $1,201 |
| Northera | None | 17 | $278,231 | $16,367 |
| Neupro | None | 155 | $167,231 | $1,079 |
| Nuplazid | Parkinson's psychosis | 37 | $142,977 | $3,864 |
| Nourianz | None | 54 | $104,612 | $1,937 |
| Inbrija | None | 15 | $77,762 | $5,184 |
| Botox | None | 57 | $71,936 | $1,262 |
| Gocovri | None | 26 | $53,287 | $2,050 |
| Carbidopa-Levodopa | None | 760 | $52,009 | $68 |
| Droxidopa | None | 17 | $47,095 | $2,770 |
| Amantadine | None | 269 | $29,249 | $109 |
| Rasagiline Mesylate | None | 35 | $17,651 | $504 |
| Entacapone | None | 85 | $14,490 | $170 |
| Carbidopa-Levodopa Er | None | 167 | $13,222 | $79 |
| Emgality | Migraine | 12 | $11,806 | $984 |
| Nurtec Odt | None | 12 | $11,252 | $938 |
| Rivastigmine | None | 173 | $9,128 | $53 |
| Linzess | None | 16 | $7,885 | $493 |
| Aimovig | Migraine | 11 | $7,702 | $700 |
| Myrbetriq | None | 11 | $6,132 | $557 |
| Carbidopa-Levodopa-Entacapone | None | 19 | $6,078 | $320 |
| Rivastigmine | None | 15 | $5,111 | $341 |
| Trulance | None | 11 | $5,044 | $459 |
| Ropinirole Er | None | 61 | $4,899 | $80 |
| Pramipexole Er | None | 12 | $4,203 | $350 |
| Pramipexole Dihydrochloride | None | 102 | $3,414 | $33 |
| Gabapentin | None | 184 | $3,330 | $18 |
| Midodrine | None | 38 | $2,767 | $73 |
| Quetiapine | None | 184 | $2,595 | $14 |
| Ramelteon | None | 29 | $2,458 | $85 |
| Propranolol Hcl Er | None | 32 | $2,427 | $76 |
| Clozapine | None | 85 | $1,976 | $23 |
| Baclofen | None | 33 | $1,943 | $59 |
| Selegiline | None | 21 | $1,793 | $85 |
| Ropinirole | None | 30 | $1,529 | $51 |
| Solifenacin | None | 14 | $1,478 | $106 |
| Fludrocortisone Acetate | None | 31 | $1,466 | $47 |
| Escitalopram | None | 112 | $1,462 | $13 |
| Memantine | None | 35 | $1,384 | $40 |
| Pregabalin | None | 46 | $1,369 | $30 |
| Topiramate | None | 40 | $1,368 | $34 |
| Galantamine Hbr | None | 26 | $1,259 | $48 |
| Clonazepam | None | 111 | $1,252 | $11 |
| Zonisamide | None | 16 | $860 | $54 |
| Primidone | None | 23 | $764 | $33 |
| Propranolol | None | 26 | $717 | $28 |
| Oxazepam | None | 24 | $712 | $30 |
| Venlafaxine Hcl Er | None | 20 | $695 | $35 |
| Nortriptyline | None | 53 | $676 | $13 |
| Fluvoxamine Maleate | None | 12 | $602 | $50 |
| Mirtazapine | None | 30 | $590 | $20 |
| Methylphenidate | None | 17 | $589 | $35 |
| Lorazepam | None | 36 | $550 | $15 |
| Amitriptyline | None | 13 | $529 | $41 |
| Donepezil | None | 40 | $502 | $13 |
| Trazodone | None | 28 | $371 | $13 |
| Naproxen | None | 11 | $370 | $34 |
| Trihexyphenidyl | None | 24 | $367 | $15 |
| Duloxetine | None | 11 | $294 | $27 |
| Sertraline | None | 27 | $233 | $9 |
| Rizatriptan | None | 14 | $128 | $9 |
| Temazepam | None | 24 | $104 | $4 |
| Zolpidem | None | 11 | $58 | $5 |
| Alprazolam | None | 11 | $53 | $5 |
| Diazepam | None | 27 | $30 | $1 |
2020: 55 drugs
| Rytary | Parkinson's | 217 | $212,607 | $980 |
| Northera | None | 15 | $204,053 | $13,604 |
| Neupro | None | 125 | $157,864 | $1,263 |
| Nuplazid | Parkinson's psychosis | 30 | $141,064 | $4,702 |
| Inbrija | None | 15 | $60,337 | $4,022 |
| Botox | None | 41 | $53,448 | $1,304 |
| Carbidopa-Levodopa | None | 654 | $35,356 | $54 |
| Xadago | None | 15 | $31,734 | $2,116 |
| Amantadine | None | 285 | $31,021 | $109 |
| Inderal La | None | 11 | $28,000 | $2,545 |
| Entacapone | None | 47 | $19,007 | $404 |
| Carbidopa-Levodopa Er | None | 128 | $10,732 | $84 |
| Carbidopa-Levodopa-Entacapone | None | 22 | $10,347 | $470 |
| Linzess | None | 17 | $9,884 | $581 |
| Rasagiline Mesylate | None | 15 | $8,364 | $558 |
| Rivastigmine | None | 114 | $8,235 | $72 |
| Ropinirole Er | None | 50 | $3,901 | $78 |
| Pramipexole Dihydrochloride | None | 100 | $3,843 | $38 |
| Pregabalin | None | 50 | $3,595 | $72 |
| Rivastigmine | None | 12 | $2,715 | $226 |
| Propranolol Hcl Er | None | 28 | $2,632 | $94 |
| Gabapentin | None | 165 | $2,520 | $15 |
| Quetiapine | None | 154 | $2,190 | $14 |
| Midodrine | None | 22 | $2,130 | $97 |
| Fludrocortisone Acetate | None | 41 | $2,054 | $50 |
| Memantine | None | 47 | $1,640 | $35 |
| Selegiline | None | 20 | $1,466 | $73 |
| Escitalopram | None | 105 | $1,383 | $13 |
| Clozapine | None | 66 | $1,272 | $19 |
| Ropinirole | None | 64 | $1,254 | $20 |
| Baclofen | None | 20 | $1,130 | $56 |
| Clonazepam | None | 112 | $912 | $8 |
| Nortriptyline | None | 58 | $844 | $15 |
| Propranolol | None | 29 | $776 | $27 |
| Methylphenidate | None | 22 | $631 | $29 |
| Oxazepam | None | 20 | $593 | $30 |
| Topiramate | None | 18 | $576 | $32 |
| Venlafaxine Hcl Er | None | 12 | $568 | $47 |
| Trazodone | None | 39 | $550 | $14 |
| Amitriptyline | None | 13 | $502 | $39 |
| Zonisamide | None | 17 | $409 | $24 |
| Trihexyphenidyl | None | 25 | $387 | $15 |
| Primidone | None | 16 | $377 | $24 |
| Mirtazapine | None | 23 | $376 | $16 |
| Sertraline | None | 21 | $276 | $13 |
| Donepezil | None | 25 | $268 | $11 |
| Lorazepam | None | 27 | $223 | $8 |
| Diazepam | None | 19 | $204 | $11 |
| Oxycodone-Acetaminophen | None | 13 | $143 | $11 |
| Paroxetine | None | 23 | $128 | $6 |
| Rizatriptan | None | 11 | $111 | $10 |
| Fluoxetine | None | 17 | $106 | $6 |
| Temazepam | None | 20 | $91 | $5 |
| Sumatriptan | None | 12 | $87 | $7 |
| Zolpidem | None | 12 | $42 | $4 |
2019: 49 drugs
| Northera | None | 26 | $307,079 | $11,811 |
| Neupro | None | 161 | $148,754 | $924 |
| Rytary | Parkinson's | 150 | $147,828 | $986 |
| Botox | None | 58 | $59,195 | $1,021 |
| Gocovri | None | 14 | $53,854 | $3,847 |
| Nuplazid | Parkinson's psychosis | 14 | $52,351 | $3,739 |
| Carbidopa-Levodopa | None | 476 | $23,428 | $49 |
| Amantadine | None | 198 | $21,638 | $109 |
| Nuedexta | None | 28 | $13,889 | $496 |
| Carbidopa-Levodopa-Entacapone | None | 30 | $12,819 | $427 |
| Entacapone | None | 25 | $12,563 | $503 |
| Pramipexole Er | None | 30 | $11,152 | $372 |
| Linzess | None | 21 | $10,363 | $493 |
| Emgality | Migraine | 11 | $7,251 | $659 |
| Rivastigmine | None | 83 | $7,076 | $85 |
| Carbidopa-Levodopa Er | None | 93 | $6,172 | $66 |
| Selegiline | None | 61 | $4,470 | $73 |
| Ropinirole Er | None | 36 | $4,386 | $122 |
| Quetiapine | None | 147 | $3,010 | $20 |
| Propranolol Hcl Er | None | 22 | $2,843 | $129 |
| Pramipexole Dihydrochloride | None | 95 | $2,516 | $26 |
| Escitalopram | None | 85 | $2,201 | $26 |
| Gabapentin | None | 113 | $1,842 | $16 |
| Januvia | None | 11 | $1,813 | $165 |
| Clozapine | None | 56 | $1,522 | $27 |
| Midodrine | None | 12 | $1,445 | $120 |
| Fludrocortisone Acetate | None | 41 | $1,182 | $29 |
| Pregabalin | None | 11 | $1,159 | $105 |
| Clonazepam | None | 72 | $963 | $13 |
| Duloxetine | None | 12 | $876 | $73 |
| Trazodone | None | 34 | $841 | $25 |
| Venlafaxine Hcl Er | None | 13 | $764 | $59 |
| Propranolol | None | 32 | $738 | $23 |
| Ropinirole | None | 23 | $719 | $31 |
| Baclofen | None | 21 | $656 | $31 |
| Nortriptyline | None | 35 | $582 | $17 |
| Methylphenidate | None | 24 | $529 | $22 |
| Topiramate | None | 23 | $417 | $18 |
| Hydrocodone-Acetaminophen | None | 19 | $342 | $18 |
| Alprazolam | None | 31 | $329 | $11 |
| Buspirone | None | 14 | $316 | $23 |
| Mirtazapine | None | 21 | $289 | $14 |
| Zonisamide | None | 15 | $280 | $19 |
| Paroxetine | None | 19 | $265 | $14 |
| Lorazepam | None | 26 | $207 | $8 |
| Zolpidem | None | 15 | $189 | $13 |
| Sertraline | None | 13 | $144 | $11 |
| Atorvastatin | None | 14 | $142 | $10 |
| Diazepam | None | 12 | $89 | $7 |
2018: 44 drugs
| Northera | None | 18 | $132,670 | $7,371 |
| Rytary | Parkinson's | 85 | $97,227 | $1,144 |
| Neupro | None | 95 | $75,751 | $797 |
| Botox | None | 66 | $70,004 | $1,061 |
| Nuplazid | Parkinson's psychosis | 11 | $33,889 | $3,081 |
| Carbidopa-Levodopa | None | 349 | $18,441 | $53 |
| Entacapone | None | 36 | $16,437 | $457 |
| Amantadine | None | 105 | $10,552 | $100 |
| Rasagiline Mesylate | None | 12 | $9,179 | $765 |
| Carbidopa-Levodopa Er | None | 96 | $5,156 | $54 |
| Linzess | None | 13 | $5,125 | $394 |
| Ropinirole Er | None | 23 | $3,364 | $146 |
| Midodrine | None | 24 | $2,903 | $121 |
| Rivastigmine | None | 46 | $2,609 | $57 |
| Selegiline | None | 28 | $1,928 | $69 |
| Pramipexole Dihydrochloride | None | 71 | $1,780 | $25 |
| Propranolol Hcl Er | None | 15 | $1,728 | $115 |
| Quetiapine | None | 77 | $1,523 | $20 |
| Gabapentin | None | 70 | $1,466 | $21 |
| Mirtazapine | None | 48 | $1,236 | $26 |
| Escitalopram | None | 61 | $1,075 | $18 |
| Clonazepam | None | 68 | $853 | $13 |
| Clozapine | None | 45 | $759 | $17 |
| Topiramate | None | 58 | $731 | $13 |
| Ropinirole | None | 28 | $657 | $23 |
| Baclofen | None | 17 | $587 | $35 |
| Propranolol | None | 21 | $586 | $28 |
| Temazepam | None | 23 | $490 | $21 |
| Hydrocodone-Acetaminophen | None | 22 | $485 | $22 |
| Trazodone | None | 32 | $431 | $13 |
| Methylphenidate | None | 16 | $315 | $20 |
| Alprazolam | None | 38 | $313 | $8 |
| Zonisamide | None | 16 | $255 | $16 |
| Nortriptyline | None | 19 | $253 | $13 |
| Zolpidem | None | 24 | $249 | $10 |
| Fludrocortisone Acetate | None | 13 | $213 | $16 |
| Tramadol | None | 11 | $128 | $12 |
| Paroxetine | None | 18 | $113 | $6 |
| Trihexyphenidyl | None | 16 | $111 | $7 |
| Benztropine Mesylate | None | 12 | $93 | $8 |
| Diazepam | None | 14 | $89 | $6 |
| Lorazepam | None | 15 | $89 | $6 |
| Lamotrigine | None | 11 | $77 | $7 |
| Atorvastatin | None | 12 | $66 | $5 |
2017: 30 drugs
| Nuplazid | Parkinson's psychosis | 38 | $62,464 | $1,644 |
| Botox | None | 59 | $60,420 | $1,024 |
| Rytary | Parkinson's | 64 | $54,994 | $859 |
| Neupro | None | 48 | $37,393 | $779 |
| Entacapone | None | 44 | $18,194 | $413 |
| Carbidopa-Levodopa | None | 186 | $9,714 | $52 |
| Amantadine | None | 39 | $5,806 | $149 |
| Carbidopa-Levodopa Er | None | 66 | $2,733 | $41 |
| Propranolol Hcl Er | None | 15 | $1,100 | $73 |
| Pramipexole Dihydrochloride | None | 44 | $928 | $21 |
| Gabapentin | None | 54 | $857 | $16 |
| Topiramate | None | 41 | $775 | $19 |
| Propranolol | None | 16 | $611 | $38 |
| Quetiapine | None | 41 | $529 | $13 |
| Baclofen | None | 17 | $418 | $25 |
| Ropinirole | None | 25 | $404 | $16 |
| Clonazepam | None | 54 | $401 | $7 |
| Zonisamide | None | 16 | $292 | $18 |
| Escitalopram | None | 30 | $289 | $10 |
| Methylphenidate | None | 12 | $240 | $20 |
| Hydrocodone-Acetaminophen | None | 16 | $230 | $14 |
| Clozapine | None | 16 | $197 | $12 |
| Nortriptyline | None | 11 | $190 | $17 |
| Zolpidem | None | 19 | $183 | $10 |
| Trazodone | None | 17 | $174 | $10 |
| Ibu | None | 12 | $99 | $8 |
| Paroxetine | None | 14 | $90 | $6 |
| Atorvastatin | None | 12 | $89 | $7 |
| Temazepam | None | 11 | $53 | $5 |
| Citalopram Hbr | None | 11 | $29 | $3 |
2016: 18 drugs
| Botox | None | 49 | $55,801 | $1,139 |
| Nuplazid | Parkinson's psychosis | 16 | $23,778 | $1,486 |
| Entacapone | None | 44 | $15,370 | $349 |
| Rytary | Parkinson's | 16 | $10,812 | $676 |
| Carbidopa-Levodopa | None | 144 | $5,497 | $38 |
| Amantadine | None | 33 | $2,700 | $82 |
| Gabapentin | None | 37 | $1,060 | $29 |
| Carbidopa-Levodopa Er | None | 49 | $1,030 | $21 |
| Topiramate | None | 52 | $763 | $15 |
| Pramipexole Dihydrochloride | None | 31 | $676 | $22 |
| Quetiapine | None | 52 | $603 | $12 |
| Baclofen | None | 21 | $575 | $27 |
| Ropinirole | None | 32 | $481 | $15 |
| Clonazepam | None | 51 | $322 | $6 |
| Levetiracetam | None | 16 | $283 | $18 |
| Hydrocodone-Acetaminophen | None | 12 | $180 | $15 |
| Trazodone | None | 18 | $161 | $9 |
| Zolpidem | None | 12 | $100 | $8 |
2015: 40 drugs
| Tecfidera | 12 | $68,250 | $5,687 |
| Botox | 24 | $27,325 | $1,139 |
| Entacapone | 43 | $11,767 | $274 |
| Lyrica | 30 | $11,097 | $370 |
| Exelon | 20 | $8,375 | $419 |
| Vimpat | 13 | $8,372 | $644 |
| Carbidopa-Levodopa | 226 | $6,444 | $29 |
| Divalproex Sodium Er | 22 | $4,852 | $221 |
| Gabapentin | 110 | $4,238 | $39 |
| Carbidopa-Levodopa Er | 57 | $2,976 | $52 |
| Pramipexole Dihydrochloride | 62 | $2,809 | $45 |
| Carbamazepine | 43 | $2,116 | $49 |
| Amantadine | 20 | $1,898 | $95 |
| Levetiracetam | 72 | $1,771 | $25 |
| Divalproex | 65 | $1,551 | $24 |
| Baclofen | 53 | $1,491 | $28 |
| Dilantin | 14 | $1,476 | $105 |
| Lamotrigine | 41 | $1,380 | $34 |
| Phenytoin Sodium Extended | 24 | $962 | $40 |
| Topiramate | 53 | $798 | $15 |
| Oxcarbazepine | 21 | $762 | $36 |
| Primidone | 36 | $713 | $20 |
| Propranolol | 39 | $690 | $18 |
| Nortriptyline | 52 | $577 | $11 |
| Quetiapine | 46 | $512 | $11 |
| Hydrocodone-Acetaminophen | 20 | $480 | $24 |
| Clonazepam | 105 | $471 | $4 |
| Phenobarbital | 15 | $470 | $31 |
| Ropinirole | 21 | $427 | $20 |
| Donepezil | 27 | $388 | $14 |
| Amitriptyline | 18 | $359 | $20 |
| Trihexyphenidyl | 13 | $241 | $19 |
| Trazodone | 35 | $228 | $7 |
| Zolpidem | 22 | $223 | $10 |
| Diazepam | 49 | $213 | $4 |
| Prednisone | 19 | $209 | $11 |
| Mirtazapine | 12 | $89 | $7 |
| Clopidogrel | 13 | $85 | $7 |
| Omeprazole | 12 | $80 | $7 |
| Simvastatin | 12 | $69 | $6 |
2014: 53 drugs
| Xenazine | 12 | $82,494 | $6,875 |
| Lyrica | 34 | $8,495 | $250 |
| Divalproex Sodium Er | 27 | $8,415 | $312 |
| Carbidopa-Levodopa | 239 | $8,267 | $35 |
| Gabapentin | 205 | $7,474 | $36 |
| Exelon | 18 | $6,115 | $340 |
| Entacapone | 16 | $4,519 | $282 |
| Pramipexole Dihydrochloride | 88 | $4,310 | $49 |
| Vimpat | 12 | $3,857 | $321 |
| Divalproex | 89 | $2,691 | $30 |
| Levetiracetam | 73 | $2,196 | $30 |
| Carbidopa-Levodopa Er | 62 | $1,678 | $27 |
| Dilantin | 18 | $1,439 | $80 |
| Oxcarbazepine | 39 | $1,282 | $33 |
| Amantadine | 13 | $1,247 | $96 |
| Sumatriptan | 22 | $1,209 | $55 |
| Carbamazepine | 50 | $1,114 | $22 |
| Quetiapine | 33 | $982 | $30 |
| Hydrocodone-Acetaminophen | 56 | $975 | $17 |
| Baclofen | 67 | $938 | $14 |
| Primidone | 47 | $826 | $18 |
| Oxycodone-Acetaminophen | 11 | $807 | $73 |
| Donepezil | 61 | $784 | $13 |
| Clonazepam | 124 | $716 | $6 |
| Phenytoin Sodium Extended | 42 | $673 | $16 |
| Topiramate | 50 | $660 | $13 |
| Oxycodone | 14 | $531 | $38 |
| Amitriptyline | 50 | $531 | $11 |
| Trihexyphenidyl | 23 | $416 | $18 |
| Phenobarbital | 24 | $411 | $17 |
| Nortriptyline | 49 | $390 | $8 |
| Ropinirole | 16 | $384 | $24 |
| Zolpidem | 45 | $373 | $8 |
| Glycopyrrolate | 11 | $340 | $31 |
| Diazepam | 53 | $309 | $6 |
| Lamotrigine | 24 | $286 | $12 |
| Tramadol | 12 | $271 | $23 |
| Propranolol | 26 | $270 | $10 |
| Prednisone | 23 | $204 | $9 |
| Omeprazole | 16 | $182 | $11 |
| Trazodone | 48 | $178 | $4 |
| Sertraline | 22 | $175 | $8 |
| Citalopram Hbr | 16 | $175 | $11 |
| Benztropine Mesylate | 18 | $159 | $9 |
| Clopidogrel | 18 | $159 | $9 |
| Methadone | 12 | $117 | $10 |
| Naproxen | 14 | $109 | $8 |
| Famotidine | 14 | $99 | $7 |
| Risperidone | 15 | $92 | $6 |
| Simvastatin | 13 | $86 | $7 |
| Lorazepam | 11 | $64 | $6 |
| Hydrochlorothiazide | 11 | $55 | $5 |
| Atenolol | 13 | $29 | $2 |
2013: 55 drugs
| Xenazine | 12 | $72,369 | $6,031 |
| Gabapentin | 210 | $11,646 | $55 |
| Carbidopa-Levodopa | 192 | $7,092 | $37 |
| Entacapone | 16 | $5,551 | $347 |
| Exelon | 11 | $5,129 | $466 |
| Namenda | 15 | $4,357 | $290 |
| Pramipexole Dihydrochloride | 73 | $4,303 | $59 |
| Levetiracetam | 93 | $4,090 | $44 |
| Lyrica | 20 | $3,674 | $184 |
| Carbidopa-Levodopa Er | 55 | $2,722 | $49 |
| Relpax | 13 | $2,436 | $187 |
| Divalproex Sodium Er | 19 | $1,888 | $99 |
| Divalproex | 77 | $1,851 | $24 |
| Sumatriptan | 18 | $1,606 | $89 |
| Hydrocodone-Acetaminophen | 101 | $1,287 | $13 |
| Clopidogrel | 21 | $1,221 | $58 |
| Topiramate | 38 | $1,158 | $30 |
| Oxcarbazepine | 27 | $1,135 | $42 |
| Dilantin | 20 | $1,026 | $51 |
| Propranolol | 57 | $950 | $17 |
| Quetiapine | 27 | $943 | $35 |
| Baclofen | 95 | $841 | $9 |
| Clonazepam | 102 | $711 | $7 |
| Glycopyrrolate | 13 | $635 | $49 |
| Oxycodone | 13 | $629 | $48 |
| Oxycodone-Acetaminophen | 21 | $608 | $29 |
| Carbamazepine | 45 | $522 | $12 |
| Phenytoin Sodium Extended | 46 | $520 | $11 |
| Donepezil | 33 | $484 | $15 |
| Amitriptyline | 89 | $477 | $5 |
| Primidone | 23 | $365 | $16 |
| Zonisamide | 18 | $351 | $19 |
| Diazepam | 47 | $306 | $7 |
| Lamotrigine | 13 | $304 | $23 |
| Cyclobenzaprine | 18 | $300 | $17 |
| Zolpidem | 45 | $273 | $6 |
| Nortriptyline | 37 | $270 | $7 |
| Escitalopram | 11 | $246 | $22 |
| Benztropine Mesylate | 24 | $195 | $8 |
| Sertraline | 20 | $181 | $9 |
| Trihexyphenidyl | 11 | $162 | $15 |
| Tramadol | 15 | $158 | $11 |
| Oxybutynin Chloride | 12 | $158 | $13 |
| Bupropion | 12 | $150 | $12 |
| Naproxen | 19 | $149 | $8 |
| Citalopram Hbr | 14 | $147 | $10 |
| Risperidone | 14 | $125 | $9 |
| Prednisone | 20 | $116 | $6 |
| Paroxetine | 11 | $100 | $9 |
| Methadone | 12 | $95 | $8 |
| Clonidine | 13 | $93 | $7 |
| Lorazepam | 13 | $91 | $7 |
| Furosemide | 13 | $85 | $7 |
| Trazodone | 20 | $75 | $4 |
| Hydrochlorothiazide | 11 | $55 | $5 |
Money from drug and device companies
$2,942 in 2025
| 2025 | 13 | 107 | $73 | $2,942 |
| 2024 | 16 | 148 | None | $3,800 |
| 2023 | 18 | 147 | None | $4,158 |
| 2022 | 21 | 176 | $800 | $4,790 |
| 2021 | 21 | 149 | $162 | $4,760 |
| 2020 | 24 | 97 | $55 | $2,025 |
| 2019 | 21 | 137 | $82 | $3,915 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ACADIA Pharmaceuticals | Nuplazid | $408 | 14 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $399 | 12 payments
|
| Abbvie | Vyalev | $398 | 17 payments
|
| MDD US Operations | None | $386 | 16 payments
|
| Boston Scientific | General - Dbs | $335 | 4 payments
|
| Neurocrine BioSciences | Ingrezza | $302 | 12 payments
|
See all 107 published payments
| Boston Scientific | Meals · 2025-12-05 | General - Dbs | $87 |
| ACADIA Pharmaceuticals | Meals · 2025-10-02 | Nuplazid | $33 |
| MDD US Operations | Meals · 2025-09-12 | None | $49 |
| ACADIA Pharmaceuticals | Meals · 2025-09-11 | Nuplazid | $32 |
| Abbvie | Meals · 2025-09-10 | Qulipta | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-09-10 | Austedo Xr | $10 |
| Boston Scientific | Meals · 2025-09-09 | General - Dbs | $97 |
| Merz Pharmaceuticals | Meals · 2025-09-08 | Inbrija | $46 |
| Abbvie | Meals · 2025-09-05 | Botox | $22 |
| Abbvie | Meals · 2025-09-04 | Vyalev | $28 |
| MDD US Operations | Meals · 2025-09-04 | None | $46 |
| Pfizer | Meals · 2025-09-02 | Nurtec Odt | $19 |
| Tanabe Pharma America | Meals · 2025-08-27 | Radicava | $34 |
| Pfizer | Meals · 2025-08-25 | Nurtec Odt | $27 |
| Abbvie | Meals · 2025-08-21 | Vyalev | $18 |
| MDD US Operations | Meals · 2025-08-20 | None | $15 |
| Medtronic | Meals · 2025-08-18 | Percept PC Brainsense | $40 |
| MDD US Operations | Meals · 2025-08-15 | None | $4 |
| ACADIA Pharmaceuticals | Meals · 2025-08-12 | Nuplazid | $35 |
| Pfizer | Meals · 2025-08-07 | Nurtec Odt | $13 |
| MDD US Operations | Meals · 2025-08-05 | None | $39 |
| Teva Pharmaceuticals USA | Meals · 2025-07-30 | Austedo Xr | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-07-29 | Austedo Xr | $33 |
| MDD US Operations | Paid to speak or teach · 2025-07-25 | None | $31 |
| Abbvie | Meals · 2025-07-23 | Botox | $24 |
| Merz Pharmaceuticals | Meals · 2025-07-23 | Inbrija | $34 |
| ACADIA Pharmaceuticals | Meals · 2025-07-22 | Nuplazid | $43 |
| ACADIA Pharmaceuticals | Meals · 2025-07-18 | Nuplazid | $29 |
| Neurocrine BioSciences | Meals · 2025-07-12 | Ingrezza | $13 |
| Neurocrine BioSciences | Meals · 2025-07-11 | Ingrezza | $25 |
| Neurocrine BioSciences | Meals · 2025-07-10 | Ingrezza | $40 |
| MDD US Operations | Paid to speak or teach · 2025-07-08 | None | $22 |
| Pfizer | Meals · 2025-07-07 | Nurtec Odt | $20 |
| Teva Pharmaceuticals USA | Meals · 2025-07-02 | Austedo Xr | $31 |
| ACADIA Pharmaceuticals | Meals · 2025-07-01 | Nuplazid | $27 |
| MDD US Operations | Meals · 2025-06-30 | None | $6 |
| MDD US Operations | Meals · 2025-06-24 | None | $9 |
| MDD US Operations | Meals · 2025-06-18 | None | $26 |
| Abbvie | Meals · 2025-06-13 | Botox | $29 |
| Neurocrine BioSciences | Meals · 2025-06-12 | Ingrezza | $37 |
| ACADIA Pharmaceuticals | Meals · 2025-06-10 | Nuplazid | $24 |
| Boston Scientific | Meals · 2025-06-04 | General - Dbs | $31 |
| Teva Pharmaceuticals USA | Meals · 2025-06-04 | Austedo Xr | $4 |
| Teva Pharmaceuticals USA | Meals · 2025-06-04 | Austedo Xr | $38 |
| MDD US Operations | Paid to speak or teach · 2025-06-03 | None | $20 |
| ACADIA Pharmaceuticals | Meals · 2025-06-03 | Nuplazid | $7 |
| Pfizer | Meals · 2025-06-02 | Nurtec Odt | $22 |
| Amneal Pharmaceuticals | Meals · 2025-05-29 | Rytary | $28 |
| Teva Pharmaceuticals USA | Meals · 2025-05-29 | Austedo Xr | $12 |
| Abbvie | Meals · 2025-05-22 | Botox | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-05-14 | Austedo Xr | $38 |
| Pfizer | Meals · 2025-05-12 | Nurtec Odt | $18 |
| ACADIA Pharmaceuticals | Meals · 2025-05-09 | Nuplazid | $24 |
| MDD US Operations | Meals · 2025-05-08 | None | $16 |
| MDD US Operations | Meals · 2025-05-07 | None | $36 |
| Amneal Pharmaceuticals | Meals · 2025-05-06 | Rytary | $24 |
| Neurocrine BioSciences | Meals · 2025-05-06 | Ingrezza | $27 |
| Neurocrine BioSciences | Meals · 2025-05-06 | Ingrezza | $17 |
| MDD US Operations | Meals · 2025-05-02 | None | $12 |
| Amneal Pharmaceuticals | Meals · 2025-05-01 | Rytary | $4 |
| Amneal Pharmaceuticals | Meals · 2025-05-01 | Rytary | $4 |
| Merz Pharmaceuticals | Meals · 2025-05-01 | Xeomin | $44 |
| Abbvie | Meals · 2025-04-29 | Botox | $25 |
| Neurocrine BioSciences | Meals · 2025-04-26 | Ingrezza | $22 |
| Pfizer | Meals · 2025-04-24 | Nurtec Odt | $23 |
| Amneal Pharmaceuticals | Meals · 2025-04-18 | Rytary | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-04-17 | Austedo Xr | $31 |
| ACADIA Pharmaceuticals | Meals · 2025-04-16 | Nuplazid | $32 |
| Abbvie | Meals · 2025-04-15 | Vyalev | $33 |
| Amneal Pharmaceuticals | Meals · 2025-04-09 | Rytary | $21 |
| Amneal Pharmaceuticals | Meals · 2025-04-04 | Rytary | $7 |
| Teva Pharmaceuticals USA | Education · 2025-04-04 | None | $101 |
| Pfizer | Meals · 2025-04-03 | Nurtec Odt | $20 |
| Boston Scientific | Meals · 2025-04-02 | General - Dbs | $121 |
| Neurocrine BioSciences | Meals · 2025-03-29 | Ingrezza | $36 |
| Neurocrine BioSciences | Meals · 2025-03-29 | Ingrezza | $3 |
| Amneal Pharmaceuticals | Meals · 2025-03-26 | Rytary | $29 |
| Abbvie | Meals · 2025-03-21 | Vyalev | $34 |
| Amneal Pharmaceuticals | Meals · 2025-03-21 | Rytary | $7 |
| Abbvie | Meals · 2025-03-19 | Qulipta | $28 |
| ACADIA Pharmaceuticals | Meals · 2025-03-19 | Nuplazid | $30 |
| Pfizer | Meals · 2025-03-17 | Nurtec Odt | $21 |
| Pfizer | Meals · 2025-03-12 | Nurtec Odt | $9 |
| Abbvie | Meals · 2025-03-07 | Qulipta | $14 |
| MDD US Operations | Meals · 2025-03-06 | None | $33 |
| Teva Pharmaceuticals USA | Meals · 2025-03-06 | Austedo Xr | $38 |
| MDD US Operations | Meals · 2025-03-01 | None | $23 |
| Pfizer | Meals · 2025-02-26 | Nurtec Odt | $21 |
| ACADIA Pharmaceuticals | Meals · 2025-02-25 | Nuplazid | $32 |
| Lundbeck | Meals · 2025-02-25 | Rexulti | $25 |
| Abbvie | Meals · 2025-02-20 | Qulipta | $19 |
| ACADIA Pharmaceuticals | Meals · 2025-02-18 | Nuplazid | $33 |
| Amneal Pharmaceuticals | Meals · 2025-02-10 | Rytary | $28 |
| Neurocrine BioSciences | Meals · 2025-02-07 | Ingrezza | $34 |
| Pfizer | Meals · 2025-02-05 | Nurtec Odt | $20 |
| Abbvie | Meals · 2025-02-04 | Qulipta | $13 |
| Lundbeck | Meals · 2025-02-04 | Rexulti | $24 |
| Abbvie | Meals · 2025-01-30 | Vyalev | $29 |
| Amneal Pharmaceuticals | Meals · 2025-01-28 | Rytary | $27 |
| Abbvie | Meals · 2025-01-27 | Ubrelvy | $18 |
| ACADIA Pharmaceuticals | Meals · 2025-01-24 | Nuplazid | $26 |
| Neurocrine BioSciences | Meals · 2025-01-23 | Ingrezza | $15 |
| Revance Therapeutics | Meals · 2025-01-22 | Daxi | $28 |
| Teva Pharmaceuticals USA | Meals · 2025-01-16 | Austedo Xr | $32 |
| Pfizer | Meals · 2025-01-15 | Nurtec Odt | $21 |
| Abbvie | Meals · 2025-01-10 | Qulipta | $10 |
| Neurocrine BioSciences | Meals · 2025-01-07 | Ingrezza | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,800
| Abbvie | Qulipta | $896 | 39 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $512 | 17 payments
|
| MDD US Operations | Apokyn | $419 | 18 payments
|
| Boston Scientific | None | $331 | 6 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $282 | 10 payments
|
| Neurocrine Biosciences | Ingrezza | $276 | 10 payments
|
| Pfizer | Nurtec Odt | $255 | 12 payments
|
| Kyowa Kirin | Nourianz | $211 | 9 payments
|
| Acorda Therapeutics | Inbrija | $201 | 11 payments
|
| Merz Pharmaceuticals | Xeomin | $100 | 3 payments
|
| Revance Therapeutics | Daxxify | $91 | 4 payments
|
| Amneal Pharmaceuticals | Rytary | $84 | 4 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $51 | 2 payments
|
| Medtronic | Percept PC Brainsense | $40 | 1 payment
|
| Lilly USA | Emgality | $29 | 1 payment
|
| Abbott Laboratories | Infinity | $25 | 1 payment
|
2023: $4,158
| Abbvie | Botox | $852 | 32 payments
|
| Boston Scientific | Vercise | $593 | 6 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $547 | 19 payments
|
| Neurocrine Biosciences | Ongentys | $407 | 12 payments
|
| MDD US Operations | None | $361 | 13 payments
|
| Acorda Therapeutics | Inbrija | $286 | 18 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $194 | 7 payments
|
| Pfizer | Nurtec Odt | $188 | 9 payments
|
| Amneal Pharmaceuticals | Rytary | $175 | 9 payments
|
| Medtronic | Percept PC Brainsense | $115 | 3 payments
|
| Impel Pharmaceuticals | Trudhesa | $98 | 5 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $93 | 4 payments
|
| Kyowa Kirin | Nourianz | $91 | 4 payments
|
| Merz Pharmaceuticals | Xeomin | $47 | 2 payments
|
| Ipsen Biopharmaceuticals | Dysport | $39 | 1 payment
|
| GE HealthCare | None | $35 | 1 payment
|
| InSightec | Exablate | $22 | 1 payment
|
| Cala Health | Cala Trio | $17 | 1 payment
|
2022: $4,790
| Global Kinetics USA | None | $800 | 1 payment
|
| Boston Scientific | General - Dbs | $788 | 19 payments
|
| Abbvie | Botox | $736 | 43 payments
|
| MDD US Operations | Xadago | $473 | 24 payments
|
| Teva Pharmaceuticals USA | Austedo | $294 | 10 payments
|
| Neurocrine Biosciences | Ingrezza | $281 | 10 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $268 | 13 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $203 | 13 payments
|
| Acorda Therapeutics | Inbrija | $184 | 11 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $179 | 9 payments
|
| Avion Pharmaceuticals | Dhivy | $148 | 7 payments
|
| Avanir Pharmaceuticals | Nuedexta | $128 | 6 payments
|
| Merz Pharmaceuticals | Xeomin | $68 | 2 payments
|
| Medtronic | Percept PC Brainsense | $47 | 1 payment
|
| Ucb | Neupro | $32 | 1 payment
|
| Abbott Laboratories | Infinity | $32 | 1 payment
|
| Lilly USA | Emgality | $31 | 1 payment
|
| GE HealthCare | None | $28 | 1 payment
|
| Kyowa Kirin | Nourianz | $26 | 1 payment
|
| Allergan | Botox | $24 | 1 payment
|
| Amneal Pharmaceuticals | Rytary | $19 | 1 payment
|
2021: $4,760
| Boston Scientific | Vercise | $1,939 | 19 payments
|
| AbbVie | Duopa | $376 | 19 payments
|
| Adamas Pharmaceuticals | Gocovri | $342 | 12 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $314 | 17 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $261 | 12 payments
|
| Teva Pharmaceuticals USA | Ajovy | $236 | 11 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $198 | 8 payments
|
| Allergan | Botox | $194 | 13 payments
|
| Neurocrine Biosciences | Ingrezza | $174 | 8 payments
|
| Ucb | Neupro | $170 | 6 payments
|
| Acorda Therapeutics | Inbrija | $162 | 7 payments
|
| Lilly USA | Emgality | $86 | 4 payments
|
| Ge Healthcare | None | $58 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $44 | 2 payments
|
| Arbor Pharmaceuticals | Horizant | $41 | 2 payments
|
| Lundbeck | Northera | $41 | 2 payments
|
| Merz Pharmaceuticals | Xeomin | $37 | 1 payment
|
| Amgen | Aimovig | $24 | 1 payment
|
| Ipsen Biopharmaceuticals | Dysport | $23 | 1 payment
|
| Medtronic | Percept | $22 | 1 payment
|
| Kyowa Kirin | Nourianz | $19 | 1 payment
|
2020: $2,025
| Allergan | Botox | $236 | 16 payments
|
| Amneal Pharmaceuticals | Rytary | $228 | 11 payments
|
| Adamas Pharmaceuticals | Gocovri | $180 | 10 payments
|
| Boston Scientific | General - Dbs | $150 | 4 payments
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $134 | 5 payments
|
| Ucb | Neupro | $126 | 5 payments
|
| Neurocrine Biosciences | Ingrezza | $113 | 4 payments
|
| AbbVie | Duopa | $98 | 5 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $95 | 7 payments
|
| Teva Pharmaceuticals USA | Ajovy | $89 | 5 payments
|
| Lundbeck | Northera | $74 | 3 payments
|
| Merz North America | Xeomin | $71 | 2 payments
|
| Acorda Therapeutics | Inbrija | $55 | 2 payments
|
| Kyowa Kirin | Nourianz | $55 | 3 payments
|
| Avanir Pharmaceuticals | Nuedexta | $50 | 2 payments
|
| Ipsen Biopharmaceuticals | Dysport | $46 | 2 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $43 | 2 payments
|
| Ge Healthcare | None | $39 | 2 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $38 | 2 payments
|
| Amgen | Aimovig | $26 | 1 payment
|
| Medtronic USA | Activa | $25 | 1 payment
|
| US WorldMeds | Apokyn | $21 | 1 payment
|
| Lilly USA | Emgality | $20 | 1 payment
|
| Novartis Pharmaceuticals | Aimovig | $15 | 1 payment
|
2019: $3,915
| Boston Scientific | General Dbs | $1,368 | 10 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $317 | 20 payments
|
| Ucb | Neupro | $308 | 13 payments
|
| Amneal Pharmaceuticals | Rytary | $253 | 13 payments
|
| Adamas Pharmaceuticals | Gocovri | $225 | 11 payments
|
| AbbVie | Duopa | $172 | 9 payments
|
| Avanir Pharmaceuticals | Nuedexta | $150 | 6 payments
|
| Allergan | Botox | $149 | 11 payments
|
| Lundbeck | Northera | $135 | 6 payments
|
| Amgen | Aimovig | $122 | 5 payments
|
| Merz North America | Xeomin | $106 | 4 payments
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $103 | 4 payments
|
| Ipsen Biopharmaceuticals | Dysport | $103 | 4 payments
|
| Vertical Pharmaceuticals | Osmolex Er | $92 | 5 payments
|
| Acorda Therapeutics | Inbrija | $82 | 4 payments
|
| Lilly USA | Emgality | $74 | 4 payments
|
| Kyowa Kirin | Nourianz | $47 | 3 payments
|
| Novartis Pharmaceuticals | Aimovig | $44 | 2 payments
|
| US WorldMeds | Apokyn | $27 | 1 payment
|
| Medtronic USA | Activa | $22 | 1 payment
|
| Sunovion Pharmaceuticals | None | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| ACADIA Pharmaceuticals Inc · Aca 16-Cac-0001 · 2019 | This clinician | $28,000 |
| ACADIA Pharmaceuticals Inc · Aca 16-Cac-0001 · 2020 | This clinician | $17,000 |
| ACADIA Pharmaceuticals Inc · Aca 16-Cac-0001 · 2021 | Their institution | $10,000 |
| Neurocrine Biosciences, Inc. · Opicapone Treatment Initiation Open-Label Study · 2023 | This clinician | $5,730 |
| US WorldMeds, LLC · Xadago Pro-Go · 2019 | Their institution | $1,578 |
| US WorldMeds, LLC · Xadago Pro-Go · 2020 | Their institution | $1,000 |
Checkups this office reported
5 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 86.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 85%That's most of the people this applied to. | 351 |
| Assessment of Cognitive Impairment or Dysfunction for Patients with Parkinson's DiseaseAs Medicare defines this measure | 19% | 79 |
| Falls: Plan of CareAs Medicare defines this measure | 100% | 73 |
| Medications listed in the chartVisits where the current medication list was documented | 97%That's most of the people this applied to. | 1,755 |
| Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and OlderAs Medicare defines this measure | 71% | 174 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Drug Cost Transparency
- Offers telehealth visits
- Records advance care plans
Professional record
- NPI
- 1780871186
- Licence
- CA A79891California A79891: Delinquent · expires 2026-03-31
- Trained
- University of Michigan Medical School, 2001
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 800 Pollard Rd Ste C30, Los Gatos, CA, 95032
- NPI first listed
- 2007-09-29
- NPI last updated
- 2017-01-25
This is when the NPI record was last certified, not a medical board exam.